Respiratory giant's revenues jump 21 percent this quarter. A balanced approach including both internal and external growth is the key to Lincare's success in the growing oxygen market, execs say. The strategy seems to be paying off, as Clearwater, FL-based Lincare Holdings Inc. beat analyst expectations and reported revenues of $244.2 million for the quarter ended Sept. 30 - that's a 21 percent increase over the same period in 2002. The respiratory giant's net income grew from $48.5 million a year ago to $60.4 million in the same time period. Lincare CEO John Byrnes says the company will continue with its success striking the right balance between "growth from internal development and acquisitions of local and regional companies." The company attributes 11 percent of its revenue increase to internal growth and 10 percent to acquisition growth. The company made three acquisitions with revenues of $2 million in the quarter. During the first nine months of 2003, Lincare purchased 11 companies with $80 million in revenues, it says. The addition of 15 new locations in the most recent quarter brings Lincare's total to 715, the company adds. Lincare's stock hit a 52-week high Oct. 21, trading at $40.05 per share.
Starting in April 2004, carriers will add the codes to their diabetic shoe edits, which enforce the following limits: no more than one pair of custom-molded shoes (including inserts provided with such shoes) and two additional pairs of inserts; or no more than one pair of depth shoes and three pairs of inserts (not including the non-customized removable inserts provided with such shoes). CMS' Web page for one-time notifications, which are part of its new online manual system and have replaced program memoranda, is at www.cms.hhs.gov/manuals/120_OTN/default.asp (see Eli's HCW, Vol. XII, No. 33, p. 262).
Hillenbrand paid $83 million in cash for the company, and could pay up to $20 million more if Advanced Respiratory hits certain revenue growth targets, it says. NHHC President and CEO Stephen Fialkow attributed the growth to expansion in the Northeast and successful integration of acquisitions over the past three years. DVI, which is in Chapter 11 bankruptcy, says it plans to work with its debtor-in-possession lenders "to maximize value through other means." and Mark Lewandowski created 30 sham DME companies and fraudulently billed Medicare for $25 million over a period of 3.5 years. The defendants improperly obtained the names and numbers of Medicare beneficiaries; billed Medicare for motorized wheelchairs, hospital beds and specialized mattresses, and enteral nutrition that was either not provided or not ordered by a physician; and created false medical records - including forged physician and patient signatures - in response to audit requests. The actions are the latest of 20 defendants' pleas in the investigation conducted by the HHS Office of Inspector General. The 20 defendants who have pled guilty include DME owners, marketers, billers and staffers, the U.S. Attorney's Office says. Christopher Plebani, who was employed by Wasserotts Medical Supply before Lake Forest, CA-based Apria Healthcare Group Inc. bought the company, went to work for Keystone. Plebani became suspicious when he observed Keystone general manager Eric Doyle, who was another Wasserotts ex-employee, allegedly scraping Apria stickers off of oxygen canisters and placing Keystone stickers over them, among other activities. When Plebani handed over a list of serial numbers to the authorities and Apria reps, Apria confirmed many of the items were stolen from it, the paper says. The state police raided the Keystone warehouse Sept. 23 and seized 66 pieces of equipment. The police say they are getting close to making arrests in the case. Doyle and Keystone owner John Joyce didn't comment for the newspaper story. The Department is reevaluating the cut and looking for a "different solution," a Department spokesperson told the Detroit Free Press. A new plan is expected next month. New Hampshire earlier called off its plans to create a wait list for Medicaid home care services after vociferous protests (see Eli's HCW, Vol. XII, No. 35, p. 280). Cambridge has recorded sales growth of 465 percent in the last five years, reaching $16.9 million in revenues in 2002, it says.